What's in Taizhou Hanzhong biomedical co. LTD's pipeline?

Taizhou Hanzhong biomedical co. LTD has 3 drugs in our index: 0 marketed, 0 filed, 3 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Taizhou Hanzhong biomedical co. LTD's portfolio?

Top competitors by shared drug class: GlaxoSmithKline, Keymed Biosciences Co.Ltd, Assistance Publique - Hôpitaux de Paris, Celltrion, Innovent Biologics (Suzhou) Co. Ltd..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/taizhou-hanzhong-biomedical-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Taizhou Hanzhong biomedical co. LTD — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Taizhou Hanzhong biomedical co. LTD pipeline: 0 marketed, 0 filed, 3 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 3 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Temozolomide + TACE	Temozolomide + TACE	phase 3	alkylating agent		Oncology
HX008	HX008	phase 3	PD-L1 inhibitor	PD-L1	Oncology
HX008 + TACE	HX008 + TACE	phase 3	PD-1 inhibitor	PD-1	Oncology

Therapeutic area mix

Oncology · 3

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

GlaxoSmithKline · 2 shared drug classes
Keymed Biosciences Co.Ltd · 2 shared drug classes
Assistance Publique - Hôpitaux de Paris · 2 shared drug classes
Celltrion · 2 shared drug classes
Innovent Biologics (Suzhou) Co. Ltd. · 2 shared drug classes
Jiangsu HengRui Medicine Co., Ltd. · 2 shared drug classes
3D Medicines (Sichuan) Co., Ltd. · 2 shared drug classes
Mabwell (Shanghai) Bioscience Co., Ltd. · 2 shared drug classes

Subscribe to ongoing alerts

Every new pipeline event for Taizhou Hanzhong biomedical co. LTD:

Cite this brief

Drug Landscape (2026). Taizhou Hanzhong biomedical co. LTD — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/taizhou-hanzhong-biomedical-co-ltd. Accessed 2026-05-17.